AVR anteris technologies global corp.

0.19%

$5.29

"Take a Closer Look", page-206

First 206 Last

Share
Profile

Follow
suckii

527 Posts.

51

29/03/17

20:20

Post #: 23719971
Share

Originally posted by Eire2011 ↑

Hi Wessomart,

Let's not get confused here. The collaboration is a seperate issue, is already underway and may or may not include any financial terms. It's in RNA Immuno-Oncology with the partner to be named at some point in the near future.

The potential partnership everyone is hoping for is as a result of good final phase 2 HSV 2 trial results and hope that they may be good enough to attract a partner for a phase 3. Keep in mind that talks with potential partners have been ongoing since the phase 1 results were released and the phase 1 results certainly raised interest from 3rd party pharma.

So yes it's all speculative but there are a couple of bows to the Vax side of the business and all will be revealed soon enough.

Meanwhile the share price will do what it does while most holders fear or suspect a cap raise (which won't happen) or fear more loss so they are getting out (at 3 year lows we know most holders are probably underwater). It has taken longer than I thought for the market to re rate this but we are not far away now. If anything this stock at 33 cents with proper management is the least risky it has ever been before.

In regards to those getting excited about the Vax partnership, I know for a fact that the market is certainly not excited, yet. Meanwhile for those with an eye for value and a stomach for volatility, now is as good a time as any to add to a holding or start a position as the potential blue sky from the Vax (and TAVR) are nowhere to be seen in the current AHZ share price. Our share price undervalues Adapt alone! This will become truly eveident in July.

Not advice and DYOR

Expand

Hi Eire2011,

You stated - 'Let's not get confused here' but after reading your post I was very confused so I thought you could clarify something for me...

1) RNA immuno-oncology with a partner or is it a collaboration?

2) The potential partnership with the phase 2 HSV 2 trial, 'What is an HSV 2 trial?

3) I think the rest of the post is good but the first two paragraphs didn't really make sense to me.

AHZ Price at posting: 34.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Trump just dropped a 200% tariff bomb. Here's how to cash in

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

AII

Inside the depths of Panasqueira: A legacy carved in rock

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

First 206 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.29		Change -0.010(0.19%)		Mkt cap ! $82.01M

Open	High	Low	Value	Volume
$5.40	$5.40	$5.20	$69.34K	13.17K

Buyers (Bids)

No.	Vol.	Price($)
1	100	$5.15

Sellers (Offers)

Price($)	Vol.	No.
$5.35	84	1

View Market Depth

No.	Vol.	Price($)
1	4000	5.120
2	1100	5.110
1	4000	5.100
1	20	5.050
2	500	5.020

Price($)	Vol.	No.
5.350	84	1
5.490	112	1
5.800	973	1
6.000	1700	1
6.300	100	1

Last trade - 15.55pm 11/07/2025 (20 minute delay)

AVR (ASX) Chart

"Take a Closer Look", page-206

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Trump just dropped a 200% tariff bomb. Here's how to cash in

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Inside the depths of Panasqueira: A legacy carved in rock

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

"Take a Closer Look", page-206

Top Stories

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Trump just dropped a 200% tariff bomb. Here's how to cash in

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Inside the depths of Panasqueira: A legacy carved in rock

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News